J. Joseph Kim
2022
In 2022, J. Joseph Kim earned a total compensation of $10.5M as Former President and Chief Executive Officer at Inovio Pharmaceuticals, a 68% increase compared to previous year.
Compensation breakdown
| Option Awards | $4,262,438 |
|---|---|
| Salary | $523,714 |
| Stock Awards | $2,979,264 |
| Other | $2,706,881 |
| Total | $10,472,297 |
Kim received $4.3M in option awards, accounting for 41% of the total pay in 2022.
Kim also received $523.7K in salary, $3M in stock awards and $2.7M in other compensation.
Rankings
In 2022, J. Joseph Kim's compensation ranked 230th out of 5,505 executives tracked by ExecPay. In other words, Kim earned more than 95.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 230 out of 5,505 | 96th |
Division Manufacturing | 89 out of 2,984 | 97th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 10 out of 458 | 98th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 6 out of 325 | 98th |
Industry Surgical and Medical Instruments and Apparatus | 5 out of 239 | 98th |
Source: SEC filing on March 28, 2023.
Kim's colleagues
We found three more compensation records of executives who worked with J. Joseph Kim at Inovio Pharmaceuticals in 2022.
News
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019